Erratum: (Neuropsychobiology (2013) 68:(168-173) :10.1159/000353613));The Link between High-Sensitivity C-Reactive Protein and Orbitofrontal Cortex in Euthymic Bipolar Disorder

Neuropsychobiology

Volumn 68, Issue 3, 2013, Pages 168-173

  Chung, Kuo Hsuan ^a,b   Huang, Shou Hung ^a,b   Wu, Jui Yu ^c   Chen, Pao Huan ^a   Hsu, Jung Lung ^b,d   Tsai, Shang Ying ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Bipolar disorder; High sensitivity C reactive protein; Orbitofrontal cortex; Wisconsin Card Sorting Test

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD LEVEL; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CORRELATION ANALYSIS; FEMALE; HIDDEN MARKOV MODEL; HUMAN; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; WISCONSIN CARD SORTING TEST;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; YOUNG ADULT;

EID: 84888267514     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000355109     Document Type: Erratum

References (35)

1. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA: Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 2008; 10: 1-37.
2. Goldberg JF, Chengappa KNR: Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disord 2009; 11: 123-137.
3. Tsai SY, Chung KH, Lee HC, Huang YL, Huang SH, Chen CC: Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord 2012; 136: 110-116.
4. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
5. Goldstein BI, Kemp DE, Soczynska JK, Mc-Intyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009; 70: 1078-1090.
6. Fiedorowicz JG, Palagummi NM, Behrendtsen O, Coryell WH: Cholesterol and affective morbidity. Psychiatry Res 2010; 175: 78-81.
7. Tsai SY, Lee HC, Chen CC: Hyperinsulinaemia associated with adrenoceptor antagonist in medicated bipolar patients during manic episode. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1038-1043.
8. Chung KH, Tsai SY, Lee HC: Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Psychiatry Clin Neurosci 2007; 61: 428-433.
9. Cunha BA, Andreazza AC, Gomes FA, Frey BN, Da Silveira LE, Goncalves CA, Kapczinski F: Investigation of serum high-sensitive Creactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2008; 258: 300-304.
10. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
11. Huang TL, Lin FC: High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 370-372.
12. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
13. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PWF: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32: 2575-2579.
14. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S, Williams SCR: Structural neuroimaging studies in major depressive disorder: meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011; 68: 675-690.
15. Rao JS, Harry GJ, Rapoport SI, Kim HW: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010; 15: 384-392.
16. Wersching H, Duning T, Lohmann H, Mohammadi S, Stehling C, Fobker M, Conty M, Minnerup J, Ringelstein EB, Berger K, Deppe M, Knecht S: Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 2010; 74: 1022-1029.
17. Liu YM, Tsai SY, Fleck DE, Strakowski SM: Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder. Psychiatry Res 2011; 189: 469-471.
18. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSMIII-R Patient Edition (SCID-P). Washington, American Psychiatric Press, 1990.
19. Strakowski ST, Tsai SY, Delbello MP, Chen CC, Fleck DE, Adler CM, Arndt S, Amicone J: Outcome following a first manic episode: cross-national US and Taiwan comparison. Bipolar Disord 2007; 9: 820-827.
20. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI singlesubject brain. Neuroimage 2002; 15: 273-289.
21. Huang SH, Tsai SY, Hsu JL, Huang YL: Volumetric reduction in various cortical regions of elderly patients with early-onset and late-onset mania. Int Psychogeriatr 2011; 23: 149-154.
22. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S: Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006; 11: 965-978.
23. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC: Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004; 79: 31-39.
24. Schoenbaum G, Roesch MR, Stalnaker TA: Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci 2006; 29: 116-124.
25. Nyhus E, Barcelo F: The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: a critical update. Brain Cogn 2009; 71: 437-451.
26. Yates DB, Dittmann S, Kapczinski F, Trentini CM: Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. J Psychiatr Res 2011; 45: 495-504.
27. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P: Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007; 9: 114-125.
28. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB: A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105-115.
29. Goldstein B, Obrzut JE, John C, Ledakis G, Armstrong CL: The impact of frontal and non-frontal brain tumor lesions on Wisconsin Card Sorting Test performance. Brain Cogn 2004; 54: 110-116.
30. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
31. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PVS, Kauer-Sant'Anna M, Klamt F, Moreira JCF, Augusto de Bittencourt Pasquali M, Fries GR, Quevedo J, Gama CS, Post R: Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011; 45: 156-161.
32. Platz EA, Sutcliffe S, De Marzo AM, Drake CG, Rifai N, Hsing AW, Hoque A, Neuhouser ML, Goodman PJ, Kristal AR: Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies. Cancer Causes Control 2010; 21: 847-851.
33. Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79: 969-973.
34. Fredrikson GN, Hedblad B, Nilsson JA, Alm R, Berglund G, Nilsson J: Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004; 53: 1436-1442.
35. Harris GJ, Barta PE, Peng LW, Lee S, Brettschneider PD, Shah A, Henderer JD, Schlaepfer TE, Pearlson GD: MR volume segmentation of gray matter and white matter using manual thresholding: dependence on image brightness. AJNR Am J Neuroradiol 1994; 15: 225-230.